Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abid Farooqi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Best Practice & Research. Clinical Rheumatology|September 12, 2008
OsteoarthritisSiddharth Kumar Das, Abid Farooqi
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|June 15, 2013
Disease activity score in rheumatoid arthritis with or without secondary fibromyalgiaShazia Zammurrad, Wajahat Munir, Abid Farooqi
The Journal of Clinical Endocrinology and Metabolism|July 5, 2003
Efficacy and safety of raloxifene 60 milligrams/day in postmenopausal Asian womenAnnie W C Kung, Hsiang-Tai Chao, Ko-En Huang, et al.
Inflammopharmacology|January 4, 2019
International multicenter randomized, placebo-controlled phase III clinical trial of β-D-mannuronic acid in rheumatoid arthritis patientsZahra Rezaieyazdi, Abid Farooqi, Hossein Soleymani-Salehabadi, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Best Practice & Research. Clinical Rheumatology|September 12, 2008
OsteoarthritisSiddharth Kumar Das, Abid Farooqi
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|June 15, 2013
Disease activity score in rheumatoid arthritis with or without secondary fibromyalgiaShazia Zammurrad, Wajahat Munir, Abid Farooqi
The Journal of Clinical Endocrinology and Metabolism|July 5, 2003
Efficacy and safety of raloxifene 60 milligrams/day in postmenopausal Asian womenAnnie W C Kung, Hsiang-Tai Chao, Ko-En Huang, et al.
Inflammopharmacology|January 4, 2019
International multicenter randomized, placebo-controlled phase III clinical trial of β-D-mannuronic acid in rheumatoid arthritis patientsZahra Rezaieyazdi, Abid Farooqi, Hossein Soleymani-Salehabadi, et al.
Pageof 1